From Cerebrospinal Fluid Neurochemistry to Clinical Diagnosis of Alzheimer’s Disease in the Era of Anti-Amyloid Treatments. Report of Four Patients

Analysis of classical cerebrospinal fluid biomarkers, especially when incorporated in a classification/diagnostic system such as the AT(N), may offer a significant diagnostic tool allowing correct identification of Alzheimer’s disease during life. We describe four patients with more or less atypical...

Descripción completa

Detalles Bibliográficos
Autores principales: Tsantzali, Ioanna, Boufidou, Fotini, Sideri, Eleni, Mavromatos, Antonis, Papaioannou, Myrto G., Foska, Aikaterini, Tollos, Ioannis, Paraskevas, Sotirios G., Bonakis, Anastasios, Voumvourakis, Konstantinos I., Tsivgoulis, Georgios, Kapaki, Elisabeth, Paraskevas, George P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533180/
https://www.ncbi.nlm.nih.gov/pubmed/34680493
http://dx.doi.org/10.3390/biomedicines9101376

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533180/
https://www.ncbi.nlm.nih.gov/pubmed/34680493
http://dx.doi.org/10.3390/biomedicines9101376

Ejemplares similares